Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: Verification with normal subjects

Journal of Glaucoma

Volumn 17, Issue 3, 2008, Pages 169-174

  Takahashi, Mami ^a   Higashide, Tomomi ^a   Sakurai, Mayumi ^a   Sugiyama, Kazuhisa ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Intraocular pressure fluctuations; Latanoprost; One eye trial

Indexed keywords

LATANOPROST;

ADULT; ARTICLE; BILATERAL EYE TREATMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE EXAMINATION; FEMALE; GLAUCOMA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; JAPANESE; MALE; ONE EYE TRIAL; PRIORITY JOURNAL; TREATMENT PLANNING;

ADMINISTRATION, TOPICAL; ADULT; ANTIHYPERTENSIVE AGENTS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; INTRAOCULAR PRESSURE; MALE; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC; TONOMETRY, OCULAR;

EID: 42149115031     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e318157a16d     Document Type: Article

References (21)

1. Shields MB. Principles of Medical Therapy for Glaucoma. Textbook of Glaucoma. 4th ed. Baltimore: Williams & Wilkins; 1998:378.
2. Ritch R, Shields MB, Krupin T. Chronic Open-angle Glaucoma: Treatment Overview. The Glaucomas. 2nd ed. St Louis: Mosby; 1996:1512.
3. Drance SM. The uniocular therapeutic trial in management of elevated IOP. Surv Ophthalmol. 1980;25:203-205.
4. Glaucoma Panel, Preferred Practice Patterns Committee. Primary Open-angle Glaucoma. San Francisco (CA): American Academy of Ophthalmology (AAO); 2005:13.
5. Realini T, Fechtner RD, Atreides SP, et al. The uniocular drug trial and second-eye response to glaucoma medications. Ophthalmology. 2004;111:421-426.
6. Realini T, Vickers WR. Symmetry of fellow-eye intraocular pressure responses to topical glaucoma medications. Ophthalmology. 2005;112:599-602.
7. Dielemans I, Vingerling JR, Hofman A, et al. Reliability of intraocular pressure measurement with the Goldmann applanation tonometer in epidemiological studies. Graefes Arch Clin Exp Ophthalmol. 1994;232:141-144.
8. Smith J, Wandel T. Rationale for the one-eye therapeutic trial. Ann Ophthalmol. 1986;18:8.
9. Alm A, Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Ophthalmology. 1995;102:1743-1752.
10. Lee PY, Shao H, Xu L, et al. The effect of prostaglandin F2α on intraocular pressure in normotensive human subjects. Invest Ophthalmol Vis Sci. 1988;29:1474-1477.
11. Villumsen J, Alm A. Prostaglandin F2α-isopropylester eye drops: effects in normal human eyes. Br J Ophthalmol. 1989;73:419-426.
12. Alm A, Villumsen J. PhXA34, a new potent ocular hypotensive drug. Arch Ophthalmol. 1991;109:1564-1568.
13. Nagasubramanian S, Sheth GP, Hitchings RA, et al. Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Ophthalmology. 1993;100:1305-1311.
14. Watson PG, Latanoprost Study Group. Latanoprost: two years' experience of its use in the United Kingdom. Ophthalmology. 1998;105:82-87.
15. Alm A, Villumsen J, Tornquist P, et al. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study. Ophthalmology. 1993;100:1312-1317.
16. Ziai N, Dolan JW, Kacere RD, et al. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol. 1993;111:1351-1358.
17. Racz P, Ruzsonyi MR, Nagy ZT, et al. Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2α analogue (PhXA41). An in-hospital, placebo-controlled study. Arch Ophthalmol. 1993;111:657-661.
18. Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The Beaver Dam eye study. Invest Ophthalmol Vis Sci. 1992;33:2224-2228.
19. Blumenthal M, Blumenthal R, Peritz E, et al. Seasonal variation in intraocular pressure. Am J Ophthalmol. 1970;69:608-610.
20. Drance SM, Crichton A, Mills RP. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma. Am J Ophthalmol. 1998;125:585-592.
21. Sit AJ, Liu JH, Weinreb RN. Asymmetry of right versus left intraocular pressures over 24 hours in glaucoma patients. Ophthalmology. 2006;113:425-430.